 | • レポートコード：MRC2106B003 • 出版社/出版日：Transparency Market Research / 2021年3月2日 • レポート形態：英文、PDF、165ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Site Licence | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Enterprise Licence | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本調査レポートは、世界の胎盤幹細胞治療市場について調査し、序論、仮定/調査手法、エグゼクティブサマリー、市場概要、キーインサイト、用途別（血液悪性腫瘍・疾患、先天性免疫不全疾患、代謝疾患、神経疾患、その他）分析、エンドユーザー別分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などを徹底分析したものです。 ・序論 ・仮定/調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・世界の胎盤幹細胞治療市場規模：用途別（血液悪性腫瘍・疾患、先天性免疫不全疾患、代謝疾患、神経疾患、その他） ・世界の胎盤幹細胞治療市場規模：エンドユーザー別 ・世界の胎盤幹細胞治療市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況 |
Placental Stem Cell Therapy Market – Scope of the Report
TMR’s report on the global placental stem cell therapy market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators for the market during the forecast period from 2020 to 2030. The report provides revenue of the global placental stem cell therapy market for the period 2018–2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global placental stem cell therapy market from 2020 to 2030.
The report has been prepared after an extensive primary and secondary researches. Primary research involved bulk of research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the placental stem cell therapy market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the placental stem cell therapy market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global placental stem cell therapy market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global placental stem cell therapy market.
The report delves into the competition landscape of the global placental stem cell therapy market. Key players operating in the global placental stem cell therapy market are identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global placental stem cell therapy market profiled in this report.
Key Questions Answered in Placental Stem Cell Therapy Market Report
What is the sales/revenue generated by the placental stem cell therapy market across all regions during the forecast period?
What are the opportunities in the global placental stem cell therapy market?
What are major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which drug class segment is expected to generate the highest revenue globally in 2030? Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Placental Stem Cell Therapy Market – Research Objectives and Research Approach
The comprehensive report on the global placental stem cell therapy market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of objectives behind this study, and key vendors and distributors operating in the market and regulatory scenario for approval of the products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global placental stem cell therapy market in terms of application, end user, and region. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2030 has also been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global placental stem cell therapy market.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Placental Stem Cell Therapy Market
4. Market Overview
4.1. Introduction
4.1.1. Application Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Placental Stem Cell Therapy Market Analysis and Forecast, 2018–2030
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Supply Chain Analysis
5.1.1. Placental Stem Cells Collection & Isolation
5.1.2. Cell processing & Cryo-preservation
5.1.3. Cell Differentiation
5.1.4. Cell Culture and Expansion
5.2. Pipeline Analysis
5.3. Regulatory Scenario, by Region/globally
5.4. Reimbursement Scenario, by Region/globally
5.5. Pricing Analysis, 2019
5.6. COVID-19 Pandemic Impact on Industry
6. Global Placental Stem Cell Therapy Market Analysis and Forecast, by Application
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Placental Stem Cell Therapy Market Value Forecast, by Application, 2018–2030
6.3.1. Hematologic Malignancies and Disorders
6.3.2. Congenital Immunodeficiency Disorders
6.3.3. Metabolic Disorders
6.3.4. Neurological Disorders
6.3.5. Others
6.4. Global Placental Stem Cell Therapy Market Attractiveness Analysis, by Application
7. Global Placental Stem Cell Therapy Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Placental Stem Cell Therapy Market Value Forecast, by End-user, 2018–2030
7.3.1. Hospitals & Specialty Clinics
7.3.2. Clinical Research Organizations
7.3.3. Research Institutes & Academies
7.4. Global Placental Stem Cell Therapy Market Attractiveness Analysis, by End-user
8. Global Placental Stem Cell Therapy Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Global Placental Stem Cell Therapy Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global Placental Stem Cell Therapy Market Attractiveness Analysis, by Country/Region
9. North America Placental Stem Cell Therapy Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. North America Placental Stem Cell Therapy Market Value Forecast, by Application, 2018–2030
9.2.1. Hematologic Malignancies and Disorders
9.2.2. Congenital Immunodeficiency Disorders
9.2.3. Metabolic Disorders
9.2.4. Neurological Disorders
9.2.5. Others
9.3. North America Placental Stem Cell Therapy Market Value Forecast, by End-user, 2018–2030
9.3.1. Hospitals & Specialty Clinics
9.3.2. Clinical Research Organizations
9.3.3. Research Institutes & Academies
9.4. North America Placental Stem Cell Therapy Market Value Forecast, by Country, 2018–2030
9.4.1. U.S.
9.4.2. Canada
9.5. North America Placental Stem Cell Therapy Market Attractiveness Analysis
9.5.1. By Application
9.5.2. By End-user
9.5.3. By Country
10. Europe Placental Stem Cell Therapy Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Europe Placental Stem Cell Therapy Market Value Forecast, by Application, 2018–2030
10.2.1. Hematologic Malignancies and Disorders
10.2.2. Congenital Immunodeficiency Disorders
10.2.3. Metabolic Disorders
10.2.4. Neurological Disorders
10.2.5. Others
10.3. Europe Placental Stem Cell Therapy Market Value Forecast, by End-user, 2018–2030
10.3.1. Hospitals & Specialty Clinics
10.3.2. Clinical Research Organizations
10.3.3. Research Institutes & Academies
10.4. Europe Placental Stem Cell Therapy Market Value Forecast, by Country/Sub-region, 2018–2030
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Placental Stem Cell Therapy Market Attractiveness Analysis
10.5.1. By Application
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Placental Stem Cell Therapy Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Asia Pacific Placental Stem Cell Therapy Market Value Forecast, by Application, 2018–2030
11.2.1. Hematologic Malignancies and Disorders
11.2.2. Congenital Immunodeficiency Disorders
11.2.3. Metabolic Disorders
11.2.4. Neurological Disorders
11.2.5. Others
11.3. Asia Pacific Placental Stem Cell Therapy Market Value Forecast, by End-user, 2018–2030
11.3.1. Hospitals & Specialty Clinics
11.3.2. Clinical Research Organizations
11.3.3. Research Institutes & Academies
11.4. Asia Pacific Placental Stem Cell Therapy Market Value Forecast, by Country/Sub-region, 2018–2030
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Asia Pacific Placental Stem Cell Therapy Market Attractiveness Analysis
11.5.1. By Application
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Placental Stem Cell Therapy Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Latin America Placental Stem Cell Therapy Market Value Forecast, by Application, 2018–2030
12.2.1. Hematologic Malignancies and Disorders
12.2.2. Congenital Immunodeficiency Disorders
12.2.3. Metabolic Disorders
12.2.4. Neurological Disorders
12.2.5. Others
12.3. Latin America Placental Stem Cell Therapy Market Value Forecast, by End-user, 2018–2030
12.3.1. Hospitals & Specialty Clinics
12.3.2. Clinical Research Organizations
12.3.3. Research Institutes & Academies
12.4. Latin America Placental Stem Cell Therapy Market Value Forecast, by Country/Sub-region, 2018–2030
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America Placental Stem Cell Therapy Market Attractiveness Analysis
12.5.1. By Application
12.5.2. By End-user
12.5.3. By Country//Sub-region
13. Middle East & Africa Placental Stem Cell Therapy Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Middle East & Africa Placental Stem Cell Therapy Market Value Forecast, by Application, 2018–2030
13.2.1. Hematologic Malignancies and Disorders
13.2.2. Congenital Immunodeficiency Disorders
13.2.3. Metabolic Disorders
13.2.4. Neurological Disorders
13.2.5. Others
13.3. Middle East & Africa Placental Stem Cell Therapy Market Value Forecast, by End-user, 2018–2030
13.3.1. Hospitals & Specialty Clinics
13.3.2. Clinical Research Organizations
13.3.3. Research Institutes & Academies
13.4. Middle East & Africa Placental Stem Cell Therapy Market Value Forecast, by Country/Sub-region, 2018–2030
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Middle East & Africa Placental Stem Cell Therapy Market Attractiveness Analysis
13.5.1. By Application
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company, 2019
14.3. Company Profiles
14.3.1. Lifebank Stem Cell Banking
14.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Strategic Overview
14.3.2. Celularity, Inc.
14.3.2.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Strategic Overview
14.3.3. Americord Registry
14.3.3.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Strategic Overview
14.3.4. ReeLabs Pvt. Ltd.
14.3.4.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Strategic Overview
14.3.5. Pluristem Therapeutics, Inc.
14.3.5.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Strategic Overview
14.3.6. Mesoblast Limited
14.3.6.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Strategic Overview
14.3.7. ReNeuron Group plc
14.3.7.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Strategic Overview
14.3.8. Athersys, Inc.
14.3.8.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Strategic Overview
14.3.9. Other Prominent Key Players